Effects of 12-O-Tetradecanoylphorbol-13-acetate on Estrogen Receptor Activity in MCF-7 Cells (*)

The effects of long term treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA) on estrogen receptor (ER) expression in the human breast cancer cell line, MCF-7, were studied. This study demonstrates that treatment of cells with the phorbol ester blocked estrogen receptor activity. Treatment of cells with 100 nM TPA resulted in an 80% decrease in the level of ER protein and a parallel decrease in ER mRNA and binding capacity. Following removal of TPA from the medium, the level of ER protein and mRNA returned to control values; however, the receptor failed to bind estradiol. These cells also failed to induce progesterone receptor in response to estradiol. In addition, TPA treatment blocked transcription from an estrogen response element in transient transfection assays and inhibited ER binding to its response element in a DNA mobility shift assay. The estrogen receptor in treated cells was recognized by two monoclonal anti-ER antibodies and was not quantitatively different from ER in control cells. RNase protection analysis failed to detect any qualitative changes in the ER mRNA transcript. Mixing experiments suggest that TPA induces/activates a factor which interacts with the ER to block binding of estradiol. The effects of TPA on ER levels and binding capacity were concentration-dependent. Low concentrations of TPA inhibited estradiol binding without a decrease in the level of protein, whereas higher concentrations were required to decrease the level of ER protein. The effects of TPA appear to be mediated by activation of protein kinase C since the protein kinase C inhibitors, H-7 and bryostatin, block the effects of TPA on estradiol induction of progesterone receptor. TPA treatment had no effect on the level or binding capacity of the glucocorticoid receptor, indicating that the effects are not universal for steroid receptors. These data demonstrate that activation of the protein kinase C signal transduction pathway modulates the estrogen receptor pathway. The long term effect of protein kinase C activation is to inhibit estrogen receptor function through induction/activation of a factor which interacts with the receptor.

[1]  D. Salomon,et al.  Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. , 1994, The Journal of biological chemistry.

[2]  S. McLeskey,et al.  Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. , 1993, Cancer research.

[3]  W. McGuire,et al.  Abnormal estrogen receptor in clinical breast cancer , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  N. Koszewski,et al.  Estrogen receptor phosphorylation. Hormonal dependence and consequence on specific DNA binding. , 1992, The Journal of biological chemistry.

[5]  M. Piccart,et al.  Accumulation of a non-binding form of estrogen receptor in MCF-7 cells under hydroxytamoxifen treatment , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[6]  W. McGuire,et al.  Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. , 1992, Cancer research.

[7]  M. Pfahl,et al.  Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradeconylphorbol-13-acetate: a molecular analysis. , 1991, Molecular endocrinology.

[8]  Y. Wang,et al.  Identification of a dominant negative form of the human estrogen receptor. , 1991, Molecular endocrinology.

[9]  W. McGuire,et al.  Estrogen receptor variants in clinical breast cancer. , 1991, Molecular endocrinology.

[10]  R. Dickson,et al.  Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate. , 1991, The Journal of biological chemistry.

[11]  M. Yaniv,et al.  Unregulated expression of c‐Jun or c‐Fos proteins but not Jun D inhibits oestrogen receptor activity in human breast cancer derived cells. , 1991, The EMBO journal.

[12]  J. Laborda,et al.  36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. , 1991, Nucleic acids research.

[13]  Y. Hashimoto,et al.  Cytosolic‐nuclear Tumor Promoter‐specific Binding Protein: Association with the 90 kDa Heat Shock Protein and Translocation into Nuclei by Treatment with 12‐O‐Tetradecanoylphorbol 13‐Acetate , 1991, Japanese journal of cancer research : Gann.

[14]  M. Beato,et al.  Hormonal regulation of vitellogenin genes: an estrogen-responsive element in the Xenopus A2 gene and a multihormonal regulatory region in the chicken II gene. , 1991, Molecular endocrinology.

[15]  P. Chambon,et al.  Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex , 1990, Cell.

[16]  S. Lindquist,et al.  Reduced levels of hsp90 compromise steroid receptor action in vivo , 1990, Nature.

[17]  B. van der Burg,et al.  Stimulation of TPA-responsive element activity by a cooperative action of insulin and estrogen in human breast cancer cells. , 1990, Molecular endocrinology.

[18]  A. Weisz,et al.  Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. , 1990, Nucleic acids research.

[19]  M. Lippman,et al.  Role of an estrogen receptor-dependent mechanism in the regulation of estrogen receptor mRNA in MCF-7 cells. , 1989, Molecular endocrinology.

[20]  I. Screpanti,et al.  Tumor-promoting phorbol ester and ras oncogene expression inhibit the glucocorticoid-dependent transcription from the mouse mammary tumor virus long terminal repeat. , 1989, Molecular endocrinology.

[21]  R. Sutherland,et al.  Modulation of estrogen receptor and epidermal growth factor receptor mRNAs by phorbol ester in MCF 7 breast cancer cells. , 1989, Biochemical and biophysical research communications.

[22]  F. Auricchio,et al.  Phosphorylation of steroid receptors. , 1989, Journal of steroid biochemistry.

[23]  P. Chambon,et al.  Regulation of the estrogen receptor in MCF-7 cells by estradiol. , 1988, Molecular endocrinology.

[24]  J. Faye,et al.  Modulation of estrogen receptors by phorbol diesters in human breast MCF-7 cell line , 1988, Molecular and Cellular Endocrinology.

[25]  D. Fabbro,et al.  Immunological quantitation of phospholipid/CA2+‐dependent protein kinase of human mammary carcinoma cells: Inverse relationship to estrogen receptors , 1987, International journal of cancer.

[26]  H. Okayama,et al.  High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.

[27]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[28]  F. Bayard,et al.  Influence of 12-O-tetradecanoylphorbol-13-acetate on proliferation and maturation of human breast carcinoma cells (MCF-7): relationship to cell cycle events. , 1987, Cancer research.

[29]  F. Auricchio,et al.  Estradiol receptor: phosphorylation on tyrosine in uterus and interaction with anti‐phosphotyrosine antibody. , 1986, The EMBO journal.

[30]  J. Darbon,et al.  Phorbol esters inhibit the proliferation of MCF-7 cells. Possible implication of protein kinase C. , 1986, Biochemical pharmacology.

[31]  D. Fabbro,et al.  Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship. , 1986, Cancer research.

[32]  B. Katzenellenbogen,et al.  Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Chambon,et al.  Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. , 1982, Nucleic acids research.

[34]  E. Jensen,et al.  Estrophilin assays in breast cancer: Quantitative features and application to the mastectomy specimen , 1980, Cancer.

[35]  W. McGuire,et al.  The value of estrogen and progesterone receptors in the treatment of breast cancer , 1980, Cancer.

[36]  R. Paridaens,et al.  Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer , 1980, Cancer.

[37]  A. Munck,et al.  Steroid-binding properties and stabilization of cytoplasmic glucocorticoid receptors from rat thymus cells. , 1973, The Biochemical journal.

[38]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[39]  B. Hirt.  Selective extraction of polyoma DNA from infected mouse cell cultures. , 1967, Journal of molecular biology.

[40]  Louis M. Hellman.  Textbook of Endocrinology , 1956, Diabetes.

[41]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[42]  W. McGuire,et al.  Variant human breast tumor estrogen receptor with constitutive transcriptional activity. , 1991, Cancer research.

[43]  G. Castoria,et al.  Direct evidence of in vitro phosphorylation-dephosphorylation of the estradiol-17 beta receptor. Role of Ca2+-calmodulin in the activation of hormone binding sites. , 1984, Journal of steroid biochemistry.

[44]  P. Blackshear.  Systems for polyacrylamide gel electrophoresis. , 1984, Methods in enzymology.